News EU Panel Recommends Luxturna for Inherited Retinal Dystrophy by Medscape • 2018/09/21 • 0 Comments The EMA's CHMP has recommended marketing authorization for voretigene neparvovec for inherited retinal dystrophy caused by RPE65 gene mutations in adults and children. International Approvals Full Story →